ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

NCI Details How Year 2000 Goals Can Be Reached Bypass Budget Spells Out How Much It Will Cost

June 8, 1984

Surgery Lowers Risk By 90% In Women With Gene Mutations

April 30, 2004

ACS Asks $1.5 Billion for NCI; Waxman Considers Requiring NIH To Send Budget Directly To Congress

March 4, 1983

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988

Abstracts Of Papers From Gynecologic Oncology Conference

October 17, 1975

Arthur Upton Will Be New NCI Director; Colleagues Convinced He’ll Be strong Leader

June 10, 1977